Kingswood Wealth Advisors LLC cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 44.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 24,454 shares of the company's stock after selling 19,772 shares during the period. Kingswood Wealth Advisors LLC's holdings in Procter & Gamble were worth $3,896,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of PG. Brighton Jones LLC raised its position in Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after acquiring an additional 13,617 shares during the period. Taylor Financial Group Inc. increased its stake in shares of Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock worth $493,000 after purchasing an additional 277 shares in the last quarter. Patriot Financial Group Insurance Agency LLC lifted its position in Procter & Gamble by 3.7% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 7,734 shares of the company's stock valued at $1,263,000 after purchasing an additional 275 shares in the last quarter. RDA Financial Network increased its position in Procter & Gamble by 12.8% in the first quarter. RDA Financial Network now owns 1,865 shares of the company's stock worth $318,000 after buying an additional 211 shares in the last quarter. Finally, Wedge Capital Management L L P NC grew its position in shares of Procter & Gamble by 2.9% during the first quarter. Wedge Capital Management L L P NC now owns 4,138 shares of the company's stock worth $705,000 after purchasing an additional 116 shares in the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Down 1.2%
Shares of PG opened at $150.47 on Tuesday. The firm has a market capitalization of $352.17 billion, a P/E ratio of 23.11, a P/E/G ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The firm has a fifty day moving average price of $155.38 and a 200-day moving average price of $159.84. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Analysts Set New Price Targets
Several research firms recently weighed in on PG. Barclays cut their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 1st. Berenberg Bank raised their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research report on Wednesday, September 17th. UBS Group set a $180.00 target price on Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. BNP Paribas Exane dropped their price target on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus price target of $173.11.
Read Our Latest Analysis on PG
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, COO Shailesh Jejurikar sold 3,986 shares of the firm's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the transaction, the chief operating officer directly owned 46,899 shares in the company, valued at $7,139,434.77. This trade represents a 7.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $1,778,655.32. Following the sale, the chief executive officer directly owned 319,932 shares of the company's stock, valued at approximately $48,703,248.36. This trade represents a 3.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 in the last ninety days. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.